MedPath

Laboratorios Osorio de Moraes Ltda.

Ownership
Private
Established
1944-01-01
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (100.0%)

Study to Assess the Efficacy and Safety of "Pílulas de Lussen®" Compared to the Pyridium® in the Symptomatic Control of Dysuria

Phase 3
Conditions
Dysuria
Interventions
First Posted Date
2009-09-01
Last Posted Date
2009-09-01
Lead Sponsor
Laboratorios Osorio de Moraes Ltda.
Target Recruit Count
80
Registration Number
NCT00969254

Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.

Phase 3
Conditions
Otitis
Efficacy
Tolerability
Interventions
Drug: Otosynalar®
First Posted Date
2009-08-27
Last Posted Date
2009-08-27
Lead Sponsor
Laboratorios Osorio de Moraes Ltda.
Target Recruit Count
188
Registration Number
NCT00967317
Locations
🇧🇷

Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.